Home › Funds › Point72 Asset Management › RYTM
Point72 Asset Management position in RYTM
RHYTHM PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)414.21K sh
Reported value held$45.99M
Portfolio Weight0.05%
First reportedQ1 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 11.96K | $213.28K | New |
| Q3 2023 | 4.15K | $95.05K | New |
| Q1 2025 | 63.84K | $3.38M | New |
| Q2 2025 | 170.83K | $10.79M | Add |
| Q4 2025 | 429.42K | $45.97M | New |
| Q1 2026 | 846.80K | $73.65M | Add |
| Q2 2026 | 414.21K | $45.99M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RYTM
- BlackRock Inc 6.16M sh · $683.60M · Q2 2026
- Vanguard Group 6.21M sh · $664.82M · Q4 2025
- JPMorgan Chase & Co 2.65M sh · $292.18M · Q2 2026
- Goldman Sachs Group 2.13M sh · $236.11M · Q2 2026
- Geode Capital Management 1.53M sh · $170.32M · Q2 2026
- Capital Research Global Investors 1.53M sh · $170.13M · Q2 2026
- Citadel Advisors 1.31M sh · $145.36M · Q2 2026
- Morgan Stanley 1.11M sh · $123.49M · Q2 2026
- Fidelity Management & Research (FMR) 1.03M sh · $113.90M · Q2 2026
- Janus Henderson Group 918.15K sh · $79.89M · Q1 2026
- Norges Bank Investment Management 685.84K sh · $76.15M · Q2 2026
- Franklin Resources 577.03K sh · $64.07M · Q2 2026